Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

Newborn screening is a fundamental right for every child, crucial for early diagnosis and intervention of preventable ...

In fact, it has already done so. Last year, it got the nod for Casgevy, a gene-editing treatment for two rare blood disorders ...

ZUG, Switzerland and BOSTON, Nov. 07, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CRSP), a biopharmaceutical company focused on ...

Crispr Therapeutics ( (CRSP) ) has released its Q3 earnings. Here is a breakdown of the information Crispr Therapeutics presented to its ...